Avoid delays and unnecessary complexity. Work with a responsive development and manufacturing partner built for complex, high‑touch programs, driven by a pioneering approach to solving challenging pharmaceutical problems.
You’re not just another project
Your program deserves focused attention and clear direction to keep progress on track.
At Douglas CDMO, we take a more focused approach. Shaped by the legacy of our pioneering founder, we bring curiosity and determination to solving challenging problems. Treating every molecule with the importance it deserves.
Our structure supports close collaboration, clear communication, and the responsiveness needed to maintain momentum at every stage.
Faster answers. Faster decisions. Faster progress.
We remove the layers that slow projects down. When you partner with Douglas CDMO, you work directly with the scientists and specialists doing the work.
This means:
- Rapid troubleshooting
- Clear scientific dialogue
- Faster, informed decisions
- Consistent support across development
With fewer handovers and direct access to expertise, progress stays steady and predictable.
Built for evolving programs
Douglas CDMO adapts to the needs of each program, whether straightforward or complex. Our teams bring thoughtful technical engagement where it adds value, helping projects progress with clarity and control.
We support clients with:
- Flexible development and manufacturing approaches
- Faster, well‑managed process adjustments
- Tailored solutions for complex or challenging program needs
- A collaborative culture built for clarity, speed, and steady progress
A smart CDMO choice for your project
Douglas CDMO is ideal for teams who want:
- A partner who treats their molecule like a priority
- A responsive, transparent working relationship
- Reliable delivery without unnecessary complexity
- The agility to adapt as programs evolve
Douglas CDMO brings deep expertise in the development and manufacturing of softgel capsules, having developed approximately one-third of pharmaceutical softgels available in the EU and U.S. markets (as at February 2025).
Recognition and awards
The FDA’s Quality Management Maturity Pilot Study
In 2024, Douglas was one of only nine companies worldwide selected to participate in the FDA’s QMM pilot study.